Appropriate Treatment of Ischemic Stroke That Is Essential for the Reduction of Mortality and Morbidity: Should We Use Hyperbaric Oxygen Therapy Together With Recombinant Tissue Plasminogen Activator for Improving Brain Oxygenation and Before Recombinant Tissue Plasminogen Activator to Minimize the Risk of Massive Bleeding?
- PMID: 34261938
- DOI: 10.1097/CCM.0000000000004988
Appropriate Treatment of Ischemic Stroke That Is Essential for the Reduction of Mortality and Morbidity: Should We Use Hyperbaric Oxygen Therapy Together With Recombinant Tissue Plasminogen Activator for Improving Brain Oxygenation and Before Recombinant Tissue Plasminogen Activator to Minimize the Risk of Massive Bleeding?
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
The authors reply.Crit Care Med. 2021 Aug 1;49(8):e807-e808. doi: 10.1097/CCM.0000000000005129. Crit Care Med. 2021. PMID: 34261939 No abstract available.
Comment on
-
Management of Acute Ischemic Stroke.Crit Care Med. 2020 Nov;48(11):1654-1663. doi: 10.1097/CCM.0000000000004597. Crit Care Med. 2020. PMID: 32947473 Free PMC article. Review.
References
-
- Herpich F, Rincon F. Management of acute ischemic stroke. Crit Care Med. 2020; 48:1654–1663
-
- Mijajlovic MD, Aleksic V, Milosevic N, et al. Hyperbaric oxygen therapy in acute stroke: Is it time for Justitia to open her eyes? Neurol Sci. 2020; 41:1381–1390
-
- Zhai WW, Sun L, Yu ZQ, et al. Hyperbaric oxygen therapy in experimental and clinical stroke. Med Gas Res. 2016; 6:111–118
-
- Efrati S, Fishlev G, Bechor Y, et al. Hyperbaric oxygen induces late neuroplasticity in post stroke patients–randomized, prospective trial. PLoS One. 2013; 8:e53716
-
- Yang ZS, Mu J. Co-administration of tissue plasminogen activator and hyperbaric oxygen in ischemic stroke: A continued promise for neuroprotection. Med Gas Res. 2017; 7:68–73
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical